XML 45 R22.htm IDEA: XBRL DOCUMENT
v3.25.4

STOCKHOLDERS’ EQUITY (Tables) | 9 Months Ended | 12 Months Ended
--- | --- | ---
Sep. 30, 2025 | Dec. 31, 2024
Equity [Abstract] |  |
SCHEDULE OF WARRANT ACTIVITY | A summary of the Company’s warrant activity and related information follows: SCHEDULE OF WARRANT ACTIVITY
|  |  |  |  |  |  |  | Weighted |
|  |  |  |  | Weighted |  |  | Average |
|  |  |  |  | Average |  |  | Remaining |
|  | Number of |  |  | Exercise |  |  | Life |
|  | Warrants |  |  | Price |  |  | In Years |
Outstanding, January 1, 2025 |  |  | 3,951,634 |  |  | $ | 5.22 |  |  |  |  |
Expired |  |  | (250 | ) |  |  | 60.00 |  |  |  |  |
Outstanding, September 30, 2025 |  |  | 3,951,384 |  |  | $ | 5.21 |  |  |  | 2.55 |
Exercisable, September 30, 2025 |  |  | 3,951,384 |  |  | $ | 5.21 |  |  |  | 2.55 |
| A summary of the warrant activity during the year ended December 31, 2024 is presented below: SCHEDULE OF WARRANT ACTIVITY
|  |  |  |  |  |  |  | Weighted |
|  |  |  |  | Weighted |  |  | Average |
|  |  |  |  | Average |  |  | Remaining |
|  | Number of |  |  | Exercise |  |  | Life |
|  | Warrants |  |  | Price |  |  | In Years |
Outstanding, January 1, 2024 |  |  | 4,791,019 |  |  | $ | 10.57 |  |  |  |  |
Granted |  |  | 2,513,686 |  |  |  | 2.43 |  |  |  |  |
Exercised |  |  | (3,351,580 | ) |  |  | 2.33 |  |  |  |  |
Expired |  |  | (1,491 | ) |  |  | 1,770 |  |  |  |  |
Outstanding, December 31, 2024 |  |  | 3,951,634 |  |  | $ | 5.22 |  |  |  | 3.30 |
Exercisable, December 31, 2024 |  |  | 3,951,634 |  |  | $ | 5.22 |  |  |  | 3.30 |
SCHEDULE OF STOCK OPTION GRANTED ASSUMPTIONS | In applying the Black-Scholes option pricing model to stock options granted, the Company used the following assumptions: SCHEDULE OF STOCK OPTION GRANTED ASSUMPTIONS
|  | For the Nine Months Ended |
|  | September 30, |
|  | 2025 |  |  | 2024 |
Risk free interest rate |  |  | 4.03 - 4.40% |  |  |  | 4.14 - 4.30% |
Expected term (years) |  |  | 2.77 - 5.38 |  |  |  | 2.77 - 5.38 |
Expected volatility |  |  | 98.14 - 99.22% |  |  |  | 101 - 102% |
Expected dividends |  |  | 0.00% |  |  |  | 0.00% |
| In applying the Black-Scholes option pricing model to stock options granted, the Company used the following assumptions: SCHEDULE OF STOCK OPTION GRANTED ASSUMPTIONS
|  | For the Years Ended |
|  | December 31, |
|  | 2024 |  |  | 2023 |
Risk free interest rate |  |  | 4.14 - 4.30% |  |  |  | 4.22 | %
Expected term (years) |  |  | 2.77 - 5.38 |  |  |  | 3.5 |
Expected volatility |  |  | 101 - 102% |  |  |  | 175.00 | %
Expected dividends |  |  | 0.00 | % |  |  | 0.00 | %
SCHEDULE OF STOCK OPTION ACTIVITY | A summary of the stock option activity during the nine months ended September 30, 2025 is presented below: SCHEDULE OF STOCK OPTION ACTIVITY
|  |  |  |  |  |  |  | Weighted |  |  |  |
|  |  |  |  | Weighted |  |  | Average |  |  |  |
|  |  |  |  | Average |  |  | Remaining |  |  |  |
|  | Number of |  |  | Exercise |  |  | Life |  |  | Intrinsic |
|  | Options |  |  | Price |  |  | In Years |  |  | Value |
Outstanding, January 1, 2025 |  |  | 3,263,467 |  |  | $ | 2.63 |  |  |  |  |  |  |  |  |
Granted |  |  | 2,177,908 |  |  |  | 2.45 |  |  |  |  |  |  |  |  |
Exercised |  |  | (29,249 | ) |  |  | 1.45 |  |  |  |  |  |  |  |  |
Forfeited |  |  | (149,153 | ) |  |  | 2.23 |  |  |  |  |  |  |  |  |
Outstanding, September 30, 2025 |  |  | 5,262,973 |  |  | $ | 2.58 |  |  |  | 7.8 |  |  | $ | - |
Exercisable, September 30, 2025 |  |  | 3,805,964 |  |  | $ | 2.72 |  |  |  | 7.3 |  |  | $ | - |
| A summary of the option activity during the year ended December 31, 2024 is presented below: SCHEDULE OF STOCK OPTION ACTIVITY
|  |  |  |  |  |  |  | Weighted |  |  |  |
|  |  |  |  | Weighted |  |  | Average |  |  |  |
|  |  |  |  | Average |  |  | Remaining |  |  |  |
|  | Number of |  |  | Exercise |  |  | Life |  |  | Intrinsic |
|  | Options |  |  | Price |  |  | In Years |  |  | Value |
Outstanding, January 1, 2024 |  |  | 1,466,892 |  |  | $ | 4.11 |  |  |  |  |  |  |  |  |
Granted |  |  | 1,934,716 |  |  |  | 1.45 |  |  |  |  |  |  |  |  |
Exercised |  |  | - |  |  |  | - |  |  |  |  |  |  |  |  |
Forfeited |  |  | (138,141 | ) |  |  | 1.76 |  |  |  |  |  |  |  |  |
Outstanding, December 31, 2024 |  |  | 3,263,467 |  |  | $ | 2.63 |  |  |  | 7.5 |  |  | $ | - |
Exercisable, December 31, 2024 |  |  | 2,499,132 |  |  | $ | 2.95 |  |  |  | 7.1 |  |  | $ | - |
SCHEDULE OF STOCK OPTION EXPENSE | The following table presents information related to stock-based compensation expense: SCHEDULE OF STOCK-BASED COMPENSATION EXPENSE
|  | 2025 |  |  | 2024 |  |  | 2025 |  |  | 2024 |  |  | 2025 |  |  | (Years) |
|  | For the Three Months Ended |  |  | For the Nine Months Ended |  |  | Unrecognized at |  |  | Weighted Average Remaining Amortization |
|  | September 30, |  |  | September 30, |  |  | September 30, |  |  | Period |
|  | 2025 |  |  | 2024 |  |  | 2025 |  |  | 2024 |  |  | 2025 |  |  | (Years) |
Research and development |  | $ | 175,398 |  |  | $ | 133,333 |  |  | $ | 1,308,322 |  |  | $ | 1,314,298 |  |  |  |  |  |  |  |  |
General and administrative |  | $ | 224,535 |  |  | $ | 150,912 |  |  | $ | 1,569,444 |  |  | $ | 1,322,643 |  |  |  |  |  |  |  |  |
Total |  | $ | 399,932 |  |  | $ | 284,245 |  |  | $ | 2,877,766 |  |  | $ | 2,636,941 |  |  | $ | 1,878,612 |  |  |  | 1.76 |
Stock-based compensation expense |  | $ | 399,932 |  |  | $ | 284,245 |  |  | $ | 2,877,766 |  |  | $ | 2,636,941 |  |  | $ | 1,878,612 |  |  | $ | 1.76 |
| The following table presents information related to stock-based compensation expense: SCHEDULE OF STOCK OPTION EXPENSE
|  | For the Years Ended December 31, |  |  | Unrecognized at December 31, |  |  | Weighted Average Remaining Amortization Period |
|  | 2024 |  |  | 2023 |  |  | 2024 |  |  | (Years) |
General and administrative |  | $ | 2,812,566 |  |  | $ | 7,782,967 |  |  | $ | 774,470 |  |  |  | 0.95 |
Total |  | $ | 2,812,566 |  |  | $ | 7,782,967 |  |  | $ | 774,470 |  |  |  | 0.95 |
SCHEDULE OF STOCK-BASED COMPENSATION EXPENSE BY AWARD TYPE | The following table presents stock-based compensation by award type: SCHEDULE OF STOCK-BASED COMPENSATION EXPENSE BY AWARD TYPE
|  | 2025 |  |  | 2024 |  |  | 2025 |  |  | 2024 |
|  | For the Three Months Ended |  |  | For the Nine Months Ended |
|  | September 30, |  |  | September 30, |
|  | 2025 |  |  | 2024 |  |  | 2025 |  |  | 2024 |
Options |  | $ | 399,932 |  |  | $ | 284,245 |  |  | $ | 2,877,766 |  |  | $ | 1,651,903 |
RSUs |  |  | - |  |  |  | - |  |  |  | - |  |  |  | 985,038 |
Total |  | $ | 399,932 |  |  | $ | 284,245 |  |  | $ | 2,877,766 |  |  | $ | 2,636,941 |
SCHEDULE OF STOCK WARRANTS |  | The following table presents information related to stock warrants at December 31, 2024: SCHEDULE OF STOCK WARRANTS
Warrants Outstanding |  |  | Warrants Exercisable |
|  |  |  |  |  | Weighted |  |  |  |
|  |  | Outstanding |  |  | Average |  |  | Exercisable |
Exercise |  |  | Number of |  |  | Remaining Life |  |  | Number of |
Price |  |  | Warrants |  |  | In Years |  |  | Warrants |
$ | 2.43 |  |  |  | 2,513,686 |  |  |  | 4.1 |  |  |  | 2,513,686 |
$ | 2.92 |  |  |  | 51,370 |  |  |  | 2.9 |  |  |  | 51,370 |
$ | 10.00 |  |  |  | 1,150,358 |  |  |  | 1.9 |  |  |  | 1,150,358 |
$ | 12.00 |  |  |  | 235,970 |  |  |  | 1.9 |  |  |  | 235,970 |
$ | 60.00 |  |  |  | 250 |  |  |  | 0.0 |  |  |  | 250 |
|  |  |  |  | 3,951,634 |  |  |  |  |  |  |  | 3,951,634 |
SCHEDULE OF INFORMATION RELATED TO STOCK OPTIONS |  | The following table presents information related to stock options at December 31, 2024: SCHEDULE OF INFORMATION RELATED TO STOCK OPTIONS
Options Outstanding |  |  | Options Exercisable |
|  |  |  |  |  | Weighted |  |  |  |
|  |  | Outstanding |  |  | Average |  |  | Exercisable |
Exercise |  |  | Number of |  |  | Remaining Life |  |  | Number of |
Price |  |  | Options |  |  | In Years |  |  | Options |
$ | 1.45 |  |  |  | 1,825,067 |  |  |  | 8.1 |  |  |  | 1,138,579 |
$ | 2.91 |  |  |  | 626,215 |  |  |  | 6.7 |  |  |  | 548,368 |
$ | 5.08 |  |  |  | 812,185 |  |  |  | 5.9 |  |  |  | 812,185 |
|  |  |  |  | 3,263,467 |  |  |  |  |  |  |  | 2,499,132 |
SCHEDULE OF UNVESTED RESTRICTED STOCK UNITS |  | A summary of the unvested RSUs as of December 31, 2024 is as follows: SCHEDULE OF UNVESTED RESTRICTED STOCK UNITS
|  | Number of Shares |
Non-vested at January 1, 2024 |  |  | 97,827 |
Granted |  |  | - |
Vested |  |  | (97,827 | )
Forfeited |  |  | - |
Non-vested at December 31, 2024 |  |  | - |

X
- Definition Tabular disclosure of cost recognized for award under share-based payment arrangement by award type. + References No definition available. + Details
Name: | BRTX_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByAwardTableTextBlock
Namespace Prefix: | BRTX_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Schedule of share based compensation warrant outstanding and exercisable by exercise price range [Table text block] + References No definition available. + Details
Name: | BRTX_ScheduleOfShareBasedCompensationWarrantOutstandingAndExercisableByExercisePriceRangeTableTextBlock
Namespace Prefix: | BRTX_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the changes in outstanding nonvested restricted stock units. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Subparagraph (f)(2) -Name Accounting Standards Codification -Paragraph 2 -Section 50 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3 + Details
Name: | us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration